YKL-40 in giant cells and macrophages from patients with giant cell arteritis
Open Access
- 1 December 1999
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (12) , 2624-2630
- https://doi.org/10.1002/1529-0131(199912)42:12<2624::aid-anr17>3.0.co;2-k
Abstract
Objective YKL‐40, a mammalian member of the family 18 glycosyl hydrolases, is secreted by activated macrophages at a late stage of differentiation. Macrophages are present in inflammation of the arterial wall and are thought to participate in the pathogenesis of giant cell arteritis (GCA). The aim of this study was to evaluate whether macrophages and giant cells of patients with GCA produce YKL‐40, and whether serum YKL‐40 concentrations are elevated in these patients. Methods Serum YKL‐40 was determined by radioimmunoassay in 19 patients with GCA and 8 patients with polymyalgia rheumatica (PMR) who were followed up prospectively during 1 year of treatment with prednisolone. Immunohistochemical staining for YKL‐40 was performed in temporal artery biopsy samples that were obtained before treatment. Results In the arteritic vessels of patients with GCA, positive staining for the YKL‐40 antigen was found in CD68+ giant cells and mononuclear cells located in the media. Macrophages located in the adventitia and intima were negative for YKL‐40. At the time of diagnosis, patients with GCA had an increased median serum level of YKL‐40 (256 μg/liter; P < 0.01) compared with healthy age‐matched controls (median 118 μg/liter), and the serum level of YKL‐40 decreased to normal levels during prednisolone treatment (–38% after 1 month; P < 0.001). Most patients with PMR had normal serum YKL‐40 levels (median 158 μg/liter) and had no changes in the serum YKL‐40 levels during prednisolone treatment. The observed changes in serum YKL‐40 did not always parallel the changes in serum C‐reactive protein levels and erythrocyte sedimentation rate during the 1‐year study period. Conclusion YKL‐40 is found in CD68+ giant cells and mononuclear cells in the media of arteritic vessels of patients with GCA, and the concentration of serum YKL‐40 may reflect the local activity of these cells in the inflamed artery.Keywords
This publication has 14 references indexed in Scilit:
- Strong Induction of Members of the Chitinase Family of Proteins in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Chitotriosidase, a chitinase, and the 39‐kDa human cartilage glycoprotein, a chitin‐binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophagesEuropean Journal of Biochemistry, 1998
- Induction and Expression of Human Cartilage Glycoprotein 39 in Rheumatoid Inflammatory and Peripheral Blood Monocyte-Derived MacrophagesExperimental Cell Research, 1997
- Molecular Characterization of the Gene for Human Cartilage gp-39 (CHI3L1), a Member of the Chitinase Protein Family and Marker for Late Stages of Macrophage DifferentiationGenomics, 1997
- Human cartilage glycoprotein‐39 as a candidate autoantigen in rheumatoid arthritisArthritis & Rheumatism, 1997
- SERUM YKL-40 LEVELS IN HEALTHY CHILDREN AND ADULTS. COMPARISON WITH SERUM AND SYNOVIAL FLUID LEVELS OF YKL-40 IN PATIENTS WITH OSTEOARTHRITIS OR TRAUMA OF THE KNEE JOINTRheumatology, 1996
- Identification of a 38-kDa Heparin-binding Glycoprotein (gp38k) in Differentiating Vascular Smooth Muscle Cells as a Member of a Group of Proteins Associated with Tissue RemodelingJournal of Biological Chemistry, 1995
- A NEW BIOCHEMICAL MARKER FOR JOINT INJURY. ANALYSIS OF YKL-40 IN SERUM AND SYNOVIAL FLUIDRheumatology, 1993
- The American College of Rheumatology 1990 criteria for the classification of giant cell arteritisArthritis & Rheumatism, 1990
- An evaluation of criteria for polymyalgia rheumatica.Annals of the Rheumatic Diseases, 1979